跳至主要内容
临床试验/NCT06288165
NCT06288165招募中不适用

Coronary Sinus Reducer Implantation for Refractory Angina - Long-Term Evaluation of Device Safety and Efficacy- Lower Silesia Sinus Reducer Registry (LSSRR)

Regional Cardiology Center, The Copper Health Centre (MCZ),2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年5月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
2
主要终点
The Clinical success - reduction of angina symptoms

研究概览

简要总结

Lower Silesia Sinus Reducer Registry is a , single-center, single-arm registry including patients with chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy who underwent Coronary Sinus Reducer implantation .

详细描述

Lower Silesia Sinus Reducer Registry is a single-center, single-arm registry including all consecutive patients who were referred to the Cardiac Department of Copper Health Center due to chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy and underwent Coronary Sinus Reducer implantation. All patients were evaluated by the local Heart Team and considered not amenable to percutaneous or surgical revascularization procedures. After the Heart Team evaluation patients were qualified for the procedure or Coronary Sinus Reducer implantation unless they met one of the exclusion criteria.

Initial patient evaluation (prior to device implantation) consisted of past medical history, actual clinical assessment with an evaluation of CCS class, Seattle Angina Questionnaire - 7 items (SAQ-7) scores, 6-min walk distance (6-MWT) test, and echocardiography. First, a follow-up visit was scheduled 1 month after the implantation procedure.The study will include clinical assessments every six months during an observation period. The primary outcomes will be gathered one year after the implantation of the CS. Nevertheless, clinical follow-up will continue for up to five years after the procedure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • present of chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy
  • Heart team evaluation with consideration of ineligibility for percutaneous or surgical revascularization procedures.

排除标准

  • recent acute coronary syndrome (<3 months),
  • recent coronary revascularization (<3 months)
  • a mean right atrial pressure higher than 15 mm Hg
  • coronary sinus proximal diameter <10mm and >14mm
  • life expectancy under 12 months,
  • advanced heart failure (New York Heart Association [NYHA] Classification - classes 3-4),
  • potential implantable cardiac resynchronization therapy defibrillator (CRT-D) implantation candidate.

结局指标

主要结局

The Clinical success - reduction of angina symptoms

时间窗: 1-Year after implantation

The severity of angina is assessed by the Canadian Cardiovascular Society Scale (CCS) class, which ranges from grade I to IV. A higher CCS grade indicates a greater severity of angina.

次要结局

  • Incidence of Treatment-Emergent Adverse Events(1-Year after implantation)
  • Reducing the severity of angina and it impact on quality of life, as shown by the Seattle Angina Questionnaire.(1-Year after implantation)
  • Change in potential aerobic capacity and endurance - The six minute walking test (6MWT)(1-Year after implantation)

研究者

发起方
Regional Cardiology Center, The Copper Health Centre (MCZ),
申办方类型
Other
责任方
Principal Investigator
主要研究者

Adrian Włodarczak

Profesaor

Regional Cardiology Center, The Copper Health Centre (MCZ),

研究点 (2)

Loading locations...

相似试验